Loading...

Molecular imaging and biochemical response assessment after a single cycle of [(225)Ac]Ac-PSMA-617/[(177)Lu]Lu-PSMA-617 tandem therapy in mCRPC patients who have progressed on [(177)Lu]Lu-PSMA-617 monotherapy

Rationale: Despite the promising results of prostate-specific membrane antigen (PSMA)-targeted (177)Lu radioligand therapy in metastatic castration-resistant prostate carcinoma (mCRPC), some patients do not respond and other patients with initially good response develop resistance to this treatment....

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Theranostics
Main Authors: Rosar, Florian, Hau, Fabian, Bartholomä, Mark, Maus, Stephan, Stemler, Tobias, Linxweiler, Johannes, Ezziddin, Samer, Khreish, Fadi
Format: Artigo
Sprog:Inglês
Udgivet: Ivyspring International Publisher 2021
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7977444/
https://ncbi.nlm.nih.gov/pubmed/33754047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.56211
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!